We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
+$7.44M
Cap. Flow %
5.12%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$6.93M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.78M
3
UNH icon
UnitedHealth
UNH
+$3.65M
4
CVS icon
CVS Health
CVS
+$3.53M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

Rank Sector Weight
1 Healthcare 48.9%
2 Financials 13.82%
3 Miscellaneous 11.7%
4 Technology 6.61%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FHTX icon
176
Foghorn Therapeutics
FHTX
$292M
$55.9K 0.04%
+11,441
New +$60.7K
RLAY icon
177
Relay Therapeutics
RLAY
$4.17B
$53.7K 0.04%
10,280
– –
ABR icon
178
CALL
Arbor Realty Trust
ABR
$979M
$52.9K 0.04%
915
+612
+202% +$7.12K
VTYX
179
DELISTED
Ventyx Biosciences
VTYX
$50.7K 0.03%
+16,295
New +$43.2K
AVXL icon
180
CALL
Anavex Life Sciences
AVXL
$265M
$49.7K 0.03%
+322
New +$3.27K
ILCV icon
181
CALL
iShares Morningstar Value ETF
ILCV
$1.36B
$49.4K 0.03%
+152
New +$13.2K
BMY icon
182
CALL
Bristol-Myers Squibb
BMY
$136B
$48.1K 0.03%
+412
New +$19.2K
YSG
183
Yatsen Holding
YSG
$250M
$45.3K 0.03%
+5,000
New +$47.6K
SLNO
184
CALL
DELISTED
Soleno Therapeutics
SLNO
$44.9K 0.03%
+115
New +$8.53K
TECX
185
CALL
Tectonic Therapeutic
TECX
$601M
$42.4K 0.03%
+229
New +$4.73K
CRMD icon
186
PUT
CorMedix
CRMD
$657M
$42.1K 0.03%
+229
New +$2.77K
ARCT icon
187
PUT
Arcturus Therapeutics
ARCT
$450M
$38.6K 0.03%
+345
New +$5.54K
SMMT icon
188
CALL
Summit Therapeutics
SMMT
$14B
$38.1K 0.03%
175
– –
RXRX icon
189
CALL
Recursion Pharmaceuticals
RXRX
$1.95B
$37.7K 0.03%
1,606
– –
ROIV icon
190
PUT
Roivant Sciences
ROIV
$25.2B
$36.3K 0.02%
+691
New +$8.55K
SRRK icon
191
CALL
Scholar Rock
SRRK
$6.74B
$35.5K 0.02%
+229
New +$8.01K
GLD icon
192
CALL
SPDR Gold Trust
GLD
$149B
$34.4K 0.02%
+42
New +$13.4K
ATYR
193
PUT
aTyr Pharma
ATYR
$48.8M
$31.3K 0.02%
176
-64,245
-100% -$291K
PRTC
194
DELISTED
PureTech Health
PRTC
$31.2K 0.02%
1,685
– –
ALT icon
195
CALL
Altimmune
ALT
$665M
$28.8K 0.02%
1,064
-1,846
-63% -$7.13K
APGE
196
CALL
DELISTED
Apogee Therapeutics
APGE
$28.7K 0.02%
295
-67
-19% -$2.56K
VTGN icon
197
CALL
VistaGen Therapeutics
VTGN
$10.8M
$28.7K 0.02%
+231
New +$690
EDIT icon
198
CALL
Editas Medicine
EDIT
$496M
$27.7K 0.02%
+693
New +$1.93K
UWMC icon
199
CALL
UWM Holdings
UWMC
$2.36B
$25.3K 0.02%
+675
New +$3.54K
TSLA icon
200
CALL
Tesla
TSLA
$1.4T
$25.1K 0.02%
+10
New +$3.47K
6 7
8
9 10

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners deployed $7.44M of net new capital in Q3 2025, opening 137 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 229,544 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $3.43M trimmed.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.